Diagnostica Stago   
Ms. Marie Compagnon-Riobe   
Registration & Reagent Documentation Manager   
125 Avenue Louis Roche   
92230 Gennevilliers, France

Re: k142132 Trade/Device Name: Pool Norm Plasma Regulation Number: 21 CFR 864.5425 Regulation Name: Multipurpose system for in vitro coagulation studies Regulatory Class: II Product Code: GGN Dated: November 4, 2014 Received: November 6, 2014

Dear Ms. Compagnon-Riobe:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the

electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Maria M. Chan -S

Maria M. Chan, Ph.D.   
Director   
Division of Immunology and Hematology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

<table><tr><td>DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use</td><td>Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.</td></tr><tr><td colspan="2">510(k) Number (if known) K142132</td></tr><tr><td colspan="2">Device Name POOL NORM</td></tr></table>

The Pool Norm is a normal human plasma pool intended for use as a normal control for the activated partial thromboplastin time (APTT) and dilute Russell's viper venom time (dRVVT) assays carried out with the following tests:

- APTT: STA $^ \mathrm { \textregistered }$ - PTT A (REF 00595) on STA- $\mathbf { \nabla } \cdot \mathbf { R } \circledast$ , STA CompCt $^ \mathrm { \textregistered }$ and STA Satellite $^ \mathrm { \textregistered }$ analyzers - dRVVT: STA $^ \mathrm { \textregistered }$ - Staclot $^ \mathrm { { \textregistered } }$ dRVV Screen (REF 00339, 00333), STA $^ \mathrm { \textregistered }$ - Staclot $^ \mathrm { \textregistered }$ dRVV Confirm (REF 00334) on STA-R $^ \mathrm { \textregistered }$ and STA Compact $^ \mathrm { \textregistered }$ analyzers.

This reagent is to be used in clinical laboratories by certified medical laboratory personnel.For in vitro diagnostic use only. For prescription use.

# FOR FDA USE ONLY

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden tmeorcollecionomationtat veragours  eonecud time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

# 510(k) Summary

Submitter's Information: Diagnostica Stago S.A.S.

125 avenue Louis Roche 92230 Gennevilliers France

# Contact Person:

Marie Compagnon-Riobé   
Registration Manager and Regulatory Affairs Coordinator   
Phone: 011-33- 1 41 47 16 11   
Fax: 011-33- 1 41 47 57 50

# Date Prepared:

December $1 2 ^ { \mathrm { t h } }$ ,2014

Device Name:

Pool Norm

# Device Classification:

Class ⅡI   
Regulation Number: 21 CFR 864.5425   
Panel: Hematology (81)   
Product Code: GGN

# Predicate Devices:

- Pooled Normal Plasma - Pre-amendment device George King Bio-Medical, INC - STA® - Control LA 1 - K061803 Diagnostica Stago

# Device Intended Use:

The Pool Norm is a normal human plasma pool intended for use as a normal control for the activated partial thromboplastin time (APTT) and dilute Russell's viper venom time (dRVVT) assays carried out with the following tests:

- APTT: STA - PTT A (REF 00595) on STA $\cdot \mathrm { R } ^ { \circledast }$ STA Compact® and STA Satellite® analyzers

dRVVT: STA - Staclot® dRVV Screen (REF 00339, 00333), STA® - Staclot® dRVV Confirm (REF 00334) on STA $\mathbf { \mathcal { R } } ^ { \mathbb { \left( B \right) } }$ and STA Compact® analyzers.

This reagent is to be used in clinical laboratories by certified medical laboratory personnel. For in vitro diagnostic use only. For prescription use.

# Device Description:

Pool Norm is a lyophilized pool of at least 20 citrated normal human plasmas, containing buffer, stabilizers and preservatives.

# Summary of precision performance data

Repeatability/Within- Laboratory Precision Study was performed in-house according to the CLSI guideline document EP05-A2 (3). Pool Norm was tested for 20 days, 2 runs per day. Test data are presented below:

- on STA-R®

<table><tr><td rowspan=2 colspan=1>Assay</td><td rowspan=2 colspan=2>SamplePool NormLot</td><td rowspan=2 colspan=2>N</td><td rowspan=2 colspan=1>X(sec)</td><td rowspan=1 colspan=2>Repeatability</td><td rowspan=1 colspan=2>Within-LaboratoryPrecision</td></tr><tr><td rowspan=1 colspan=1>SD(sec)</td><td rowspan=1 colspan=1>CV(%)</td><td rowspan=1 colspan=1>SD(sec)</td><td rowspan=1 colspan=1>CV(%)</td></tr><tr><td rowspan=6 colspan=1>STA® - PTT A</td><td rowspan=1 colspan=2>110150</td><td rowspan=2 colspan=2>80</td><td rowspan=1 colspan=1>33.1</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=4 colspan=2>110795</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=3 colspan=2></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=2 colspan=1>b</td><td rowspan=2 colspan=1>32.6</td><td rowspan=2 colspan=1>0.3</td><td rowspan=2 colspan=1>1.0</td><td rowspan=2 colspan=1>0.5</td><td rowspan=2 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=2>o0</td></tr><tr><td rowspan=1 colspan=2>111289</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>32.5</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=5 colspan=1>STA® - Staclot®dRVV Screen</td><td rowspan=1 colspan=2>110150</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>42.4</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=3 colspan=2>110795</td><td rowspan=3 colspan=1></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=2 colspan=1>80</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>41.6</td><td rowspan=1 colspan=1>0.2</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=2>111289</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>41.2</td><td rowspan=1 colspan=1>0.2</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.1</td></tr><tr><td rowspan=5 colspan=1>STA® - Staclot®dRVV confirm</td><td rowspan=1 colspan=2>110150</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>38.2</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=3 colspan=2>110795</td><td rowspan=1 colspan=2></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=2 colspan=2>80</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>37.9</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=2>111289</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>37.7</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>1.1</td></tr></table>

- on STA Compact®   

<table><tr><td rowspan=2 colspan=1>Assay</td><td rowspan=2 colspan=1>SamplePool NormLot</td><td rowspan=2 colspan=3>N</td><td rowspan=2 colspan=1>X(sec)</td><td rowspan=1 colspan=2>Repeatability</td><td rowspan=1 colspan=2>Within-LaboratoryPrecision</td></tr><tr><td rowspan=1 colspan=1>SD(sec)</td><td rowspan=1 colspan=1>CV(%)</td><td rowspan=1 colspan=1>SD(sec)</td><td rowspan=1 colspan=1>CV(%)</td></tr><tr><td rowspan=3 colspan=1>STA® - PTT A</td><td rowspan=1 colspan=1>110150</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>33.0</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>2.1</td></tr><tr><td rowspan=1 colspan=1>110795</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=2>80</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>32.7</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>111289</td><td rowspan=1 colspan=2>−</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>32.5</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>2.1</td></tr><tr><td rowspan=3 colspan=1>STA - StaclotdRVV Screen</td><td rowspan=1 colspan=1>110150</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>40.5</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>110795</td><td rowspan=1 colspan=2>80</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>40.0</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>111289</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>39.4</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=3 colspan=1>STA - StaclotdRVV confirm</td><td rowspan=2 colspan=1>110150110795</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>37.0</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=2></td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>36.5</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>111289</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>36.4</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.4</td></tr></table>

- on STA Satellite®   

<table><tr><td rowspan=2 colspan=1>Assay</td><td rowspan=2 colspan=1>SamplePool NormLot</td><td rowspan=2 colspan=3>N</td><td rowspan=2 colspan=1>X(sec)</td><td rowspan=1 colspan=2>Repeatability</td><td rowspan=1 colspan=2>Within-LaboratoryPrecision</td></tr><tr><td rowspan=1 colspan=1>SD(sec)</td><td rowspan=1 colspan=1>CV(%)</td><td rowspan=1 colspan=1>SD(sec)</td><td rowspan=1 colspan=1>CV(%)</td></tr><tr><td rowspan=4 colspan=1>STA - PTT A</td><td rowspan=1 colspan=1>110150</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>33.5</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=2 colspan=1>110795</td><td rowspan=2 colspan=2>80</td><td rowspan=1 colspan=2>90</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>33.1</td><td rowspan=2 colspan=1>0.1</td><td rowspan=2 colspan=1>0.2</td><td rowspan=2 colspan=1>0.3</td></tr><tr><td rowspan=2 colspan=3>80</td></tr><tr><td rowspan=1 colspan=1>111289</td><td rowspan=1 colspan=1>33.1</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.9</td></tr></table>

# Substantial Equivalence Comparison Table:

<table><tr><td colspan="1" rowspan="1">Attributes orCharacteristics</td><td colspan="1" rowspan="1">Pool Norm(Diagnostica Stago)Subject device</td><td colspan="1" rowspan="1">Pooled Normal Plasma(George King Bio-Medical)Predicate device</td><td colspan="1" rowspan="1">STA® - Control LA 1(Diagnostica Stago)Predicate device</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Normal control for theactivated partialthromboplastin time(APTT) and diluteRussell's viper venomtime (dRVVT) assayscarried out with thefollowing tests: APTT: STA® - PTT A(REF 00595) on STA-R, STA Compact® andSTA Satellite® analyzers dRVVT: STA -Staclot® dRVV Screen(REF 00339, 00333),STA - Staclot dRVVConfirm (REF 00334) onSTA-R   and   STACompact® analyzers.This reagent is to be usedin clinical laboratories bycertified          medicallaboratory personnel. Forin vitro diagnostic useonly.Forprescriptionuse.</td><td colspan="1" rowspan="1">Control plasma intendedto be used to monitorcoagulation tests.For in vitro diagnosticuse only.</td><td colspan="1" rowspan="1">Lupus      anticoagulantLA) negativeplasmaintended for the qualitycontrol of the tests forLA detection carried outwith the followingtests:− STA - Staclot dRVVScreen  (REF 00339,00333) STA - Staclot® dRVVConfirm (REF 00334)Staclot® LA (REF00600, 00594).For in vitro diagnosticuse only.</td></tr><tr><td colspan="1" rowspan="1">Assay valuesreporting</td><td colspan="1" rowspan="1">Lot-specific Certificateof analysis:- reporting assay valuesfor Activated  PartialThromboplastin    Time(APTT),certifying  negativetesting     for     lupusanticoagulant.</td><td colspan="1" rowspan="1">Lot-specific Certificateof analysis:- reporting assay valuesfor Prothrombin Time(PT), Activated PartialThromboplastin Time(APTT), Fibrinogen,Factors V, VII, VIII, IX,X, XI and XII</td><td colspan="1" rowspan="1">Lot-specific Certificateof analysis:- reporting controlvalues forSTA - Staclot® dRVVScreen, STA - Staclot®dRVV Confirm andStaclot® LA</td></tr><tr><td colspan="1" rowspan="1">Test procedure</td><td colspan="1" rowspan="1">Same manner as patients'samples</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Automatically used bythe instruments</td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">Pooled citrated humanplasma from normaldonors</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">LA negative citratedhuman plasma</td></tr><tr><td colspan="1" rowspan="1">Form</td><td colspan="1" rowspan="1">Lyophilized</td><td colspan="1" rowspan="1">Frozen</td><td colspan="1" rowspan="1">Lyophilized</td></tr><tr><td colspan="1" rowspan="1">In-use stability</td><td colspan="1" rowspan="1">8 hours at 20 ± 5 </td><td colspan="1" rowspan="1">2 hours after beingthawed at 37 °C</td><td colspan="1" rowspan="1">*8 hours at 20 ± 5 °C*8 hours on the STACompact® and STA-R</td></tr><tr><td colspan="1" rowspan="1">AnatomicalSites</td><td colspan="1" rowspan="1">Not applicable. No directpatient contact</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Storage</td><td colspan="1" rowspan="1">2-8 °</td><td colspan="1" rowspan="1">≤ - 70 °</td><td colspan="1" rowspan="1">2-8 °C</td></tr><tr><td colspan="1" rowspan="1">Sterility</td><td colspan="1" rowspan="1">No sterility requirements.No direct patient contact</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Biocompatibility</td><td colspan="1" rowspan="1">No biocompatibilityrequirements. No directpatient contact</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Chemical Safety</td><td colspan="1" rowspan="1">No issues regardingchemical safety due to nodirect patient contact</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr></table>